Reuters: Regulatory News: DOJ drops inquiry against DaVita without charges

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

DOJ drops inquiry against DaVita without charges Oct 2nd 2012, 11:00 Tue Oct 2, 2012 7:00am EDT Oct 2 (Reuters) - Dialysis clinic operator DaVita Inc said the U.S. Department of Justice dropped its seven-year-long civil and criminal investigation into its financial and marketing practices and that no charges would be filed. The investigation initiated by the U.S. Attorney's Office (USAO) for St. Louis in 2005 covered the company's joint ventures, financial relationships with physicians and services provided to patients, and included the administration and billing of DaVita's anemia drug, Epogen. "The USAO closed its investigation without filing any charges, without demanding any payments and without seeking any changes in company policies," DaVita said in a statement. DaVita said in October 2011 that it was the subject of another government investigation into payments for infusion drugs covered by the Medicaid health program for the poor in New York. Shares of Denver, Colorado-based DaVita closed at $103.44 on Monday on the New York Stock Exchange.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions